More Multichannel Articles

Multichannel

The rise and rise of digital budgets

Andrew Stone, (Mar 10, 2022)

Spending on digital promotional and educational activity will continue to rise while promotional budgets for print decline
Multichannel

Making medicines sustainable

Andrew Stone, (Nov 30, 2021)

There’s a new cross-healthcare initiative to cut medicines waste and lower carbon emissions while also improving healthcare equity and serving patients.  Pharma will be a key player
Multichannel

The evolution of the pharma incubator

Andrew Stone, (Nov 2, 2021)

Smarter use of venture capital, leveraging physical co-location, collaborating with the big tech accelerators and broad industry innovation consortia should help pharma incubators address the rapidly growing digital health sector
Multichannel

Speeding pharma’s slow sustainability journey

Andrew Stone, (Nov 2, 2021)

There’s much more pharma could and should do to drive positive change in the climate fight and action is no longer optional 
Multichannel

Expanding the horizons of home health

Andrew Stone, (Sep 27, 2021)

Home health is nothing new, but the pandemic has demonstrated the possibilities for new home health models thanks to new tech and new approaches
Multichannel

How well is pharma incubating innovation?

Andrew Stone, (Jul 7, 2021)

Incubators are starting to prove their worth by enabling pharma to explore new tech and by challenging pharma’s internal culture
Multichannel

Innovating with the wizards of AI

Andrew Stone, (Jul 5, 2021)

New applications for AI are opening up vast possibilities in healthcare if pharma can collaborate to innovate
Multichannel

How US pharma is charting a new course in a changed world

Tom Disley, (Apr 6, 2021)

Post-Trump and post pandemic, pharma in the US is eyeing emerging commercial and clinical opportunities, but must reckon with potential storms ahead
Multichannel

Building capacity in digital

Katie Osborne, (Feb 22, 2021)

The new era of digital-first engagement demands new approaches to scaling by harnessing technology, seeing content creation as collaborative and cultivating a startup culture
Access and Evidence

Bringing innovation to rare disease patients in Europe

Izzy Gladstone, (Feb 17, 2021)

Johanna Friedl-Naderer, President, Europe, Canada & Partner Markets, Biogen on how collaboration between governments and industry can lead to better patient outcomes.

Pages